机译:患有新诊断的多发性骨髓瘤患者的骨密度利用
Institute of Hematology Davidoff Cancer Center Beilinson HospitalRabin Medical CenterPetah‐Tikva;
Sackler School of MedicineTel‐Aviv UniversityTel‐Aviv Israel;
Sackler School of MedicineTel‐Aviv UniversityTel‐Aviv Israel;
Statistical unit Research departmentRabin Medical CenterPetah‐Tikva Israel;
The Raphael Recanati Genetic InstituteRabin Medical CenterPetah‐Tikva Israel;
Institute of Hematology Davidoff Cancer Center Beilinson HospitalRabin Medical CenterPetah‐Tikva;
Institute of Hematology Davidoff Cancer Center Beilinson HospitalRabin Medical CenterPetah‐Tikva;
Institute of Hematology Davidoff Cancer Center Beilinson HospitalRabin Medical CenterPetah‐Tikva;
multiple myeloma; BMD; osteoporosis; osteolytic lesions;
机译:患有新诊断的多发性骨髓瘤患者的骨密度利用
机译:新诊断的多发性骨髓瘤和阴燃性骨髓瘤患者在进行诊断性骨髓活检时无症状免疫球蛋白轻链淀粉样变性(AL)。 144例病例报道及文献复习
机译:新诊断的多发性骨髓瘤中骨髓微血管密度增加预后较差。
机译:使用转移学习检测多发性骨髓瘤患者的骨病变
机译:150名新诊断的多发性骨髓瘤患者的成纤维细胞生长因子受体3(FGFR3)的突变,SNP和同工型分析。
机译:患有新诊断的多发性骨髓瘤的患者的多个髓外骨相关和/或髓外骨是独立的预后因素
机译:NaF-PET / CT在多发性骨髓瘤中的作用:与健康对照组相比,评估新诊断的骨髓瘤患者在基线时的骨重塑